To date, the majority of emerging adult T1D intervention research has examined the use of advanced diabetes management technology (eg, CGM) [19-21] and closed-loop insulin delivery [22, 23] or on optimizing the transition from the pediatric to the adult health care systems [24-26]. The gene discussed is INS; the disease is type 1 diabetes mellitus.